T. Rowe Price Associates’s TScan Therapeutics TCRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-15,479
| Closed | -$22K | – | 3146 |
|
|
2025
Q1 | $22K | Hold |
15,479
| – | – | ﹤0.01% | 3000 |
|
|
2024
Q4 | $48K | Buy |
15,479
+3,178
| +26% | +$9.86K | ﹤0.01% | 2940 |
|
|
2024
Q3 | $62K | Hold |
12,301
| – | – | ﹤0.01% | 2903 |
|
|
2024
Q2 | $0 | Buy |
+12,301
| New | – | ﹤0.01% | 3028 |
|